Urine odor analyzer might better diagnose bladder cancer | MassDevice.com On Call

MassDevice On Call

MASSDEVICE ON CALL — Inspired by studies demonstrating canine abilities to sniff out cancerous biomarkers, a team of U.K. researchers developed a scent-analysis device that they say can diagnose early signs of bladder cancer.

In a test of nearly 100 urine samples, the device, called OdorReader, was 100% accurate in distinguishing which samples came from cancer patients, researchers said. As an added bonus, the system delivers its diagnosis in just 30 minutes, according to a press release.

Researchers hope the technology may be able to detect cancer earlier than current urine-testing methods.

"Each year approximately 10,000 people in the UK are diagnosed with bladder cancer," University of Liverpool’s Institute of Translational Medicine professor Chris Probert said in prepared remarks. "It is a disease that, if caught early, can be treated effectively, but unfortunately we do not have any early screening methods other than diagnosis through urine tests at the stage when it starts to become a problem."

The device, which features a sensor that interprets fumes from urine and attempts to detect the presence of cancerous cells, may be able to dramatically cut bladder cancer treatment costs, according to the release.

"Bladder cancer is said to be the most expensive cancer to treat, due to repeated scopes to inspect the development of the cancer cells in the bladder," Probert added. "OdorReader has the potential to dramatically cut these costs by preventing scopes."

 Non-surgical specialists perform almost half of sarcoma surgeries
Dangerous sarcomas, located deep in muscle tissue, are removed by surgeons specifically trained to do so in only 52% of cases, according to a review by the University of Southern California Davis Health System.

The other 48% of sarcoma removals were in the hands of non-oncological surgeons, such as orthopedic or plastic surgeons. This data led the U.S. National Comprehensive Cancer Network to rethink guidelines for soft tissue sarcomas.
Read more

 Embedded code might be tracking health-related web browsing
Popular health-related websites are rife with 3rd-party programs that quietly track use and gather data,
, according to research from Marco Huesch from the University of Southern California.

Huesch found that 3rd-parties are embedding code that gathers browsing patterns on highly-trafficked medical websites. Of the 20 popular health websites he examined, all had an average of 6 or 7 embedded programs that tracked potentially sensitive data.
Read more

 2 new small biotechs opening doors in Mass.
ZS Genetics and Boston Biomedical this week both celebrated ribbon-cutting ceremonies at brick-and-mortar locations in Massachusetts.

ZS Genetics, a DNA sequencing company, opened doors in Wakefield for its 10 employees, who have been working remotely since the company founded 6 years ago.

Boston Biomedical’s new location will also serve as the global oncology center for parent company Dainippon Sumitomo Pharma, which bought out the small Boston Biomedical last year. Boston Biomedical has been operating out of the Cambridgeport office since winter, but the ribbon-cutting ceremony was delayed because of this year’s snowstorms.
Read more

 SmartMetric is selling its EMR key ring to the public
SmartMetric is taking to the airwaves with a radio campaign surrounding its portable electronic health record keyring. The keyring, about the size of a flash drive, is protected with a fingerprint "key" that unlocks the files.

Similar to a metal medical wristband, the keyring is for people who want to keep important medical information with them at all times. Company CEO Chaya Hendrick said a radio campaign is the most direct way to reach customers.
Read more

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply